Adult-Type Diffuse Glioma — Trials

Adult-Type Diffuse Glioma — Trials · CancerIndex

Clinical trials

Registered studies

1,869 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 510
Recruiting: 273
Ph III recruiting: 18
Growth YoY: +40.7%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (296)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06329570	Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)	suspended	Phase 1 / Phase 2	10	NaviFUS CorporationINDUSTRY	1	Sep 9, 2026	clinicaltrials
NCT06806228	Phase I Pilot Study to Evaluate the Anti-glioblastoma Effect of S-Gboxin in Standard Treatment of Glioblastoma/Diffuse Midline Glioma and Response to Treatment (Regardless of Mutation Status)	suspended	Phase 1	10	Petrov, AndreyOTHER	3	Jun 3, 2026